The extracellular part of glycoprotein E of bovine herpesvirus 1 is sufficient for complex formation with glycoprotein I but not for cell-to-cell spread

2000 ◽  
Vol 145 (2) ◽  
pp. 333-351 ◽  
Author(s):  
J. Tyborowska ◽  
K. Bieńkowska-Szewczyk ◽  
M. Rychłowski ◽  
J. T. Van Oirschot ◽  
F. A. M. Rijsewijk
Viruses ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 1025
Author(s):  
Hocine Yezid ◽  
Christian T. Lay ◽  
Katrin Pannhorst ◽  
Shafiqul I. Chowdhury

Bovine herpesvirus 1 (BHV-1) causes respiratory infection and abortion in cattle. Following a primary infection, BHV-1 establishes lifelong latency in the trigeminal ganglia (TG). Periodic reactivation of the latent virus in TG neurons results in anterograde virus transport to nerve endings in the nasal mucosa and nasal virus shedding. The BHV-1 glycoprotein E cytoplasmic tail (gE-CT) is necessary for virus cell-to-cell spread in epithelial cells and neuronal anterograde transport. Recently, we identified two tyrosine residues, Y467 and Y563, within the tyrosine-based motifs 467YTSL470 and 563YTVV566, which, together, account for the gE CT-mediated efficient cell-to-cell spread of BHV-1 in epithelial cells. Here, we determined that in primary neuron cultures in vitro, the individual alanine exchange Y467A or Y563A mutants had significantly diminished anterograde axonal spread. Remarkably, the double-alanine-exchanged Y467A/Y563A mutant virus was not transported anterogradely. Following intranasal infection of rabbits, both wild-type (wt) and the Y467A/Y563A mutant viruses established latency in the TG. Upon dexamethasone-induced reactivation, both wt and the mutant viruses reactivated and replicated equally efficiently in the TG. However, upon reactivation, only the wt, not the mutant, was isolated from nasal swabs. Therefore, the gE-CT tyrosine residues Y467 and Y563 together are required for gE CT-mediated anterograde neuronal transport.


2000 ◽  
Vol 145 (5) ◽  
pp. 921-936 ◽  
Author(s):  
F. A. M. Rijsewijk ◽  
M. J. Kaashoek ◽  
J. P. M. Langeveld ◽  
M. A. Maris-Veldhuis ◽  
J. Magdalena ◽  
...  

2017 ◽  
Vol 28 (4) ◽  
pp. 248-252 ◽  
Author(s):  
Sachin S. Pawar ◽  
Chetan D. Meshram ◽  
Niraj K. Singh ◽  
Mohini Saini ◽  
B. P. Mishra ◽  
...  

2016 ◽  
Vol 36 (11) ◽  
pp. 1067-1074
Author(s):  
Marcelo Weiss ◽  
◽  
Deniz Anziliero ◽  
Mathias Martins ◽  
Rudi Weiblen ◽  
...  

ABSTRACT: A glycoprotein E-deleted Brazilian bovine herpesvirus 1 (BoHV-1gEΔ) was tested regarding to safety and immunogenicity. Intramuscular inoculation of young calves with a high virus dose did not result in clinical signs or virus shedding during acute infection or after dexamethasone administration. Calves vaccinated once IM (group I) or subcutaneously (group II) with live BoHV-1gEΔ or twice with inactivated virus plus aluminum hydroxide (group IV) or Montanide™ (group V) developed VN titers of 2 to 8 (GMT:2); 2 to 4 (GMT:1.65); 2 to 16 (GMT:2.45) and 2 to 128 (GMT:3.9), respectively. All BoHV-1gEΔ vaccinated calves remained negative in an anti-gE ELISA. Lastly, six young calves vaccinated with live BoHV-1gEΔ and subsequently challenged with a virulent BoHV-1 strain shed less virus and developed only mild and transient nasal signs comparing to unvaccinated calves. Thus, the recombinant BoHV-1gEΔ is safe and immunogenic for calves and allows for serological differentiation by a gE-ELISA test.


2015 ◽  
Vol 48 (9) ◽  
pp. 843-851 ◽  
Author(s):  
M. Weiss ◽  
M.C.S. Brum ◽  
D. Anziliero ◽  
R. Weiblen ◽  
E.F. Flores

Vaccine ◽  
2001 ◽  
Vol 19 (15-16) ◽  
pp. 1924-1930 ◽  
Author(s):  
M.H Mars ◽  
M.C.M de Jong ◽  
P Franken ◽  
J.T van Oirschot

2006 ◽  
Vol 113 (3-4) ◽  
pp. 303-308 ◽  
Author(s):  
Julien Thiry ◽  
Maria Tempesta ◽  
Michele Camero ◽  
Elvira Tarsitano ◽  
Anna Lucia Bellacicco ◽  
...  

2006 ◽  
Vol 87 (8) ◽  
pp. 2149-2154 ◽  
Author(s):  
Benoît Muylkens ◽  
François Meurens ◽  
Frédéric Schynts ◽  
Frédéric Farnir ◽  
Aldo Pourchet ◽  
...  

Vaccines used in control programmes of Bovine herpesvirus 1 (BoHV-1) utilize highly attenuated BoHV-1 strains marked by a deletion of the glycoprotein E (gE) gene. Since BoHV-1 recombinants are obtained at high frequency in experimentally coinfected cattle, the consequences of recombination on the virulence of gE-negative BoHV-1 were investigated. Thus, gE-negative BoHV-1 recombinants were generated in vitro from several virulent BoHV-1 and one mutant BoHV-1 deleted in the gC and gE genes. Four gE-negative recombinants were tested in the natural host. All the recombinants were more virulent than the gE-negative BoHV-1 vaccine and the gC- and gE-negative parental BoHV-1. The gE-negative recombinant isolated from a BoHV-1 field strain induced the highest severe clinical score. Latency and reactivation studies showed that three of the recombinants were reexcreted. Recombination can therefore restore virulence of gE-negative BoHV-1 by introducing the gE deletion into a different virulence background.


1996 ◽  
Vol 48 (1-2) ◽  
pp. 143-153 ◽  
Author(s):  
M.J. Kaashoek ◽  
F.A.C. van Engelenburg ◽  
A. Moerman ◽  
A.L.J. Gielkens ◽  
F.A.M. Rijsewijk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document